The U.S. Food and Drug Administration (FDA) will schedule a public meeting of the Medical Devices Advisory Committee later this year to discuss study results, real-world data, and other...

Related Keywords

Michael Sjoding ,Health Care Viewpoints ,Drug Administration ,Devices Advisory Committee ,Medical Devices Advisory Committee ,Medical Devices Workshop ,New England Journal ,Diversity Plans ,Improve Enrollment ,Participants From Underrepresented Racial ,Ethnic Populations ,Clinical Trials ,Clinical Trial Populations ,Eligibility Criteria ,Enrollment Practices ,Trial Designs ,